Cell therapy: types, regulation, and clinical benefits
AEH El-Kadiry, M Rafei, R Shammaa - Frontiers in Medicine, 2021 - frontiersin.org
Cell therapy practices date back to the 19th century and continue to expand on
investigational and investment grounds. Cell therapy includes stem cell-and non–stem cell …
investigational and investment grounds. Cell therapy includes stem cell-and non–stem cell …
Regulatory mechanism of M1/M2 macrophage polarization in the development of autoimmune diseases
Y Peng, M Zhou, H Yang, R Qu, Y Qiu… - Mediators of …, 2023 - Wiley Online Library
Macrophages are innate immune cells in the organism and can be found in almost tissues
and organs. They are highly plastic and heterogeneous cells and can participate in the …
and organs. They are highly plastic and heterogeneous cells and can participate in the …
T follicular helper cells and T follicular regulatory cells in autoimmune diseases
J Qi, C Liu, Z Bai, X Li, G Yao - Frontiers in Immunology, 2023 - frontiersin.org
T follicular helper (Tfh) cells are heterogeneous and mainly characterized by expressing
surface markers CXCR5, ICOS, and PD-1; cytokine IL-21; and transcription factor Bcl6. They …
surface markers CXCR5, ICOS, and PD-1; cytokine IL-21; and transcription factor Bcl6. They …
[HTML][HTML] Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19
M Wang, W Chang, L Zhang… - International Journal of …, 2022 - ncbi.nlm.nih.gov
The rapid dissemination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the causative agent of coronavirus disease 2019 (COVID-19), remains a global public health …
the causative agent of coronavirus disease 2019 (COVID-19), remains a global public health …
[HTML][HTML] Vitiligo and chronic autoimmune thyroiditis
Vitiligo, the discoloration of the skin, has different autoimmune mechanisms reflected by
many biomarkers as shown by skin histology, staining for CD4 and CD8 T lymphocytes …
many biomarkers as shown by skin histology, staining for CD4 and CD8 T lymphocytes …
Extracellular vesicles and their cells of origin: Open issues in autoimmune diseases
The conventional therapeutic approaches to treat autoimmune diseases through
suppressing the immune system, such as steroidal and non-steroidal anti-inflammatory …
suppressing the immune system, such as steroidal and non-steroidal anti-inflammatory …
The enzymatic poly(gallic acid) reduces pro-inflammatory cytokines in vitro, a potential application in inflammatory diseases
Abstract Cytokines like IL-6, TNF-α, and IL-1β are important mediators of inflammation in
many inflammatory diseases, as well as in cellular processes like cell proliferation and cell …
many inflammatory diseases, as well as in cellular processes like cell proliferation and cell …
Immunotherapy deriving from CAR‐T cell treatment in autoimmune diseases
Y Chen, J Sun, H Liu, G Yin… - Journal of Immunology …, 2019 - Wiley Online Library
Chimeric antigen receptor T (CAR‐T) cells are T cells engineered to express specific
synthetic antigen receptors that can recognize antigens expressed by tumor cells, which …
synthetic antigen receptors that can recognize antigens expressed by tumor cells, which …
[HTML][HTML] Beyond cells: The extracellular circulating 20S proteasomes
Accumulating evidence arising from numerous clinical studies indicate that assembled and
functional 20S proteasome complexes circulate freely in plasma. Elevated levels of this core …
functional 20S proteasome complexes circulate freely in plasma. Elevated levels of this core …
Forecasting of potential anti-inflammatory targets of some immunomodulatory plants and their constituents using in vitro, molecular docking and network …
Most synthetic immunomodulatory medications are extremely expensive, have many
disadvantages and suffer from a lot of side effects. So that, introducing immunomodulatory …
disadvantages and suffer from a lot of side effects. So that, introducing immunomodulatory …